
Contents
Reference intervals—biochemistry
-
Published:September 2020
Cite
All laboratory discourse is probabilistic.
Drugs may interfere with any chemical method; as these effects may be method dependent, it is difficult for us to be aware of all possibilities. If in doubt, discuss with the lab.
Substance . | Specimen . | Normal value . |
---|---|---|
Adrenocorticotrophic hormone | P | <80ng/L |
Alanine aminotransferase (alt) | P | 5–35IU/L |
Albumin | P¶ | 35–50g/L |
Aldosterone | P** | 100–500pmoL/L |
Alkaline phosphatase | P¶ | 30–300IU/L (adults) |
α-fetoprotein | S | <10kU/L |
α-amylase | P | 0–180 Somogyi U/dL |
Angiotensin II | P** | 5–35pmol/L |
Antidiuretic hormone (adh) | P | 0.9–4.6pmol/L |
Aspartate transaminase | P | 5–35IU/L |
Bicarbonate | P¶ | 24–30mmol/L |
Bilirubin | P | 3–17µmol/L (0.25–1.5mg/100/mL) |
Calcitonin | P | <0.1mcg/L |
Calcium (ionized) | P | 1.0–1.25mmol/L |
Calcium (total) | P¶ | 2.12–2.65mmol/L |
Chloride | P | 95–105mmol/L |
*Cholesterol | P | <5mmol/L desired |
Triglycerides | P | 0.15–1.9mmol/L |
ldl | P | 1.55–4.4mmol/L |
hdl | P | 0.9–1.93mmol/L |
Cortisol | P | a.m. 450–700nmol/L midnight 80–280nmol/L |
Creatine kinase (ck) | P | ♂ 25–195IU/L; ♀ 25–170 |
Creatinine (related to lean body mass) | P¶ | 70–≤150µmol/L |
Ferritin | P | 12–200mcg/L |
Folate | S | 2.1mcg/L |
Follicle-stimulating hormone (fsh) | P/S | 2–8U/L (luteal): ovulatory peak 8–15 follicular phase, & ♂: 0.5–5 postmenopausal: >30 |
Gamma-glutamyl transpeptidase | P | ♂ 11–51; ♀ 7–33IU/L |
Glucose (fasting) | P | 3.5–5.5mmol/L |
Growth hormone | B | <20mU/L |
HbA1c ifcc | P | 20–42mmol/mol |
Iron | S | ♂ 14–31µmol/L; ♀ 11–30 |
Lactate dehydrogenase (ldh) | P | 70–250U/L |
Lead | B | <1.8mmol/L |
Luteinizing hormone (lh) | P/S | premenopausal: 3–16U/L follicular: 3–12 ovulatory peak: 20–80 luteal: 3–16 postmenopausal: >l30 |
Magnesium | P | 0.75–1.05mmol/L |
Osmolality | P | 278–305mosmol/kg |
Parathyroid hormone (pth) | P | <0.8–8.5pmol/L |
Phosphate (inorganic) | P | 0.8–1.45mmol/L |
Potassium | P | 3.5–5.0mmol/L |
Prolactin | P | ♂ <450u/L; ♀ <600U/L |
Prostate-specific antigen | P | 0–4 mcg/mL |
Protein (total) | P | 60–80g/L |
Red cell folate | B | 0.36–1.44µmol/L (160–640mcg/L) |
Renin (erect/recumbent) | P** | 2.8–4.5/1.1–2.7pmol/mL/h |
Sodium | P¶ | 135–145mmol/L |
Thyroid-binding globulin (tbg) | P | 7–17mg/L |
Thyroid-stimulating hormone (tsh) NR widens with age | P | 0.5–5.7mU/L |
Thyroxine (t4) | P | 70–140nmol/L |
Thyroxine (free) | P | 9–22pmol/L |
Total iron binding capacity | S | 54–75µmol/L |
Tri-iodothyroine (t3) | P | 1.2–3.0nmol/L |
Urea | P¶ | 2.5–6.7mmol/L |
Urate | P¶ | ♂ 210–480µmol/L ♀ 150–390µmol/L |
Vitamin b12 | S | 0.13–0.68nmol/L (>150ng/L) |
Vitamin D | S | 60–105nmol/L |
Substance . | Specimen . | Normal value . |
---|---|---|
Adrenocorticotrophic hormone | P | <80ng/L |
Alanine aminotransferase (alt) | P | 5–35IU/L |
Albumin | P¶ | 35–50g/L |
Aldosterone | P** | 100–500pmoL/L |
Alkaline phosphatase | P¶ | 30–300IU/L (adults) |
α-fetoprotein | S | <10kU/L |
α-amylase | P | 0–180 Somogyi U/dL |
Angiotensin II | P** | 5–35pmol/L |
Antidiuretic hormone (adh) | P | 0.9–4.6pmol/L |
Aspartate transaminase | P | 5–35IU/L |
Bicarbonate | P¶ | 24–30mmol/L |
Bilirubin | P | 3–17µmol/L (0.25–1.5mg/100/mL) |
Calcitonin | P | <0.1mcg/L |
Calcium (ionized) | P | 1.0–1.25mmol/L |
Calcium (total) | P¶ | 2.12–2.65mmol/L |
Chloride | P | 95–105mmol/L |
*Cholesterol | P | <5mmol/L desired |
Triglycerides | P | 0.15–1.9mmol/L |
ldl | P | 1.55–4.4mmol/L |
hdl | P | 0.9–1.93mmol/L |
Cortisol | P | a.m. 450–700nmol/L midnight 80–280nmol/L |
Creatine kinase (ck) | P | ♂ 25–195IU/L; ♀ 25–170 |
Creatinine (related to lean body mass) | P¶ | 70–≤150µmol/L |
Ferritin | P | 12–200mcg/L |
Folate | S | 2.1mcg/L |
Follicle-stimulating hormone (fsh) | P/S | 2–8U/L (luteal): ovulatory peak 8–15 follicular phase, & ♂: 0.5–5 postmenopausal: >30 |
Gamma-glutamyl transpeptidase | P | ♂ 11–51; ♀ 7–33IU/L |
Glucose (fasting) | P | 3.5–5.5mmol/L |
Growth hormone | B | <20mU/L |
HbA1c ifcc | P | 20–42mmol/mol |
Iron | S | ♂ 14–31µmol/L; ♀ 11–30 |
Lactate dehydrogenase (ldh) | P | 70–250U/L |
Lead | B | <1.8mmol/L |
Luteinizing hormone (lh) | P/S | premenopausal: 3–16U/L follicular: 3–12 ovulatory peak: 20–80 luteal: 3–16 postmenopausal: >l30 |
Magnesium | P | 0.75–1.05mmol/L |
Osmolality | P | 278–305mosmol/kg |
Parathyroid hormone (pth) | P | <0.8–8.5pmol/L |
Phosphate (inorganic) | P | 0.8–1.45mmol/L |
Potassium | P | 3.5–5.0mmol/L |
Prolactin | P | ♂ <450u/L; ♀ <600U/L |
Prostate-specific antigen | P | 0–4 mcg/mL |
Protein (total) | P | 60–80g/L |
Red cell folate | B | 0.36–1.44µmol/L (160–640mcg/L) |
Renin (erect/recumbent) | P** | 2.8–4.5/1.1–2.7pmol/mL/h |
Sodium | P¶ | 135–145mmol/L |
Thyroid-binding globulin (tbg) | P | 7–17mg/L |
Thyroid-stimulating hormone (tsh) NR widens with age | P | 0.5–5.7mU/L |
Thyroxine (t4) | P | 70–140nmol/L |
Thyroxine (free) | P | 9–22pmol/L |
Total iron binding capacity | S | 54–75µmol/L |
Tri-iodothyroine (t3) | P | 1.2–3.0nmol/L |
Urea | P¶ | 2.5–6.7mmol/L |
Urate | P¶ | ♂ 210–480µmol/L ♀ 150–390µmol/L |
Vitamin b12 | S | 0.13–0.68nmol/L (>150ng/L) |
Vitamin D | S | 60–105nmol/L |
Arterial blood gases . | |
---|---|
pH: 7.35–7.45 | PaCO2: 4.7–6.0kPa |
PaO2: <10.6kPa | Base excess: ± 2mmol/L nb: 7.6mmHg = 1kPa (atmospheric pressure ≈ 100kPa) |
Arterial blood gases . | |
---|---|
pH: 7.35–7.45 | PaCO2: 4.7–6.0kPa |
PaO2: <10.6kPa | Base excess: ± 2mmol/L nb: 7.6mmHg = 1kPa (atmospheric pressure ≈ 100kPa) |
Month: | Total Views: |
---|---|
October 2022 | 3 |
November 2022 | 4 |
December 2022 | 6 |
February 2023 | 13 |
March 2023 | 10 |
April 2023 | 12 |
May 2023 | 2 |
June 2023 | 4 |
July 2023 | 3 |
August 2023 | 8 |
September 2023 | 5 |
October 2023 | 4 |
November 2023 | 2 |
December 2023 | 3 |
January 2024 | 5 |
February 2024 | 4 |
March 2024 | 1 |
April 2024 | 4 |
May 2024 | 7 |
June 2024 | 12 |
July 2024 | 14 |
August 2024 | 6 |
September 2024 | 6 |
October 2024 | 10 |
November 2024 | 1 |
December 2024 | 9 |
January 2025 | 1 |
February 2025 | 4 |
March 2025 | 10 |
April 2025 | 6 |
May 2025 | 1 |